Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: April 7, 2003
Last updated: July 17, 2013
Last verified: October 2006
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given